Sucampo Pharma (SCMP) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil slips on weaker demand outlook and higher US stocks amid supply disruptions
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Sucampo Reports First Quarter 2015 Financial Results and Corporate Update
May 6, 2015 6:30 AM EDTStrong Financial Performance Driven by Continued Revenue and Sales Growth of AMITIZA
Strong Growth in Net Income and EPS
Company Confirms 2015 Earnings Guidance
Company to Host Conference Call Today at 8:30 a.m. Eastern
BETHESDA, Md., May 6, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq: SCMP) today reported consolidated financial results for the first quarter ended March 31, 2015.
Sucampo reported year-over-year growth of 33% to $29.5 million in total revenue, 17% to $15.7... More
